β-Amyloid peptide fragment 31-35 induces apoptosis in cultured cortical neurons

Neuroscience

Volumn 92, Issue 1, 1999, Pages 177-184

  Yan, X Z ^a   Qiao, J T ^a   Dou, Y ^a   Qiao, Z D ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

amyloid peptide fragment 31 35; Apoptosis; Cultured neurons; DNA fragmentation; Flow cytometry; Neurodegeneration

Indexed keywords

AMYLOID BETA PROTEIN; CELL DNA;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DEGRADATION; FLOW CYTOMETRY; MOUSE; NERVE CELL CULTURE; NERVE CELL DEGENERATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AMYLOID BETA-PROTEIN; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; AURINTRICARBOXYLIC ACID; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; DACTINOMYCIN; DNA FRAGMENTATION; FLOW CYTOMETRY; MICE; NEURONS; PEPTIDE FRAGMENTS;

EID: 0033036691     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00727-1     Document Type: Article

References (37)

1. Batistatou A., Greene L.A. Aurintricarboxylic acid rescues PC12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: correlation with suppression of endonuclease activity. J. Cell Biol. 115:1991;461-471.
2. Benzing W.C., Mufson E.J., Armstrong D.M. Alzheimer's disease-like dystrophic neurites characteristically associated with senile plaques are not found within other neurodegenerative diseases unless amyloid β-protein deposition is present. Brain Res. 606:1993;10-18.
3. Carson D.A., Ribeiro J.M. Apoptosis and disease. Lancet. 341:1993;1251-1254.
4. Copani A.M., Koh J.Y., Cotman C.W. β-Amyloid increases neuronal susceptibility to injury by glucose deprivation. NeuroReport. 2:1991;763-765.
5. Cotman C.W., Pike C.J., Copani A. β-Amyloid neurotoxicity: a discussion of in vitro findings. Neurobiol. Aging. 13:1992;587-590.
6. Cotman C.W., Anderson A.J. A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Molec. Neurobiol. 10:1995;19-45.
7. Dessi F., Christiane C., Khrestchatisky M., Ben Y. Glutamate-induced neuronal death is not a programmed cell death in cerebellar culture. J. Neurochem. 60:1993;1953-1955.
8. Endresen P.C., Prytz P.S., Aarbakke J. A new flow cytometric method for discrimination of apoptotic cells and detection of their cell cycle specificity through staining of F-actin and DNA. Cytometry. 20:1995;162-171.
9. Gerschenson L.E., Rotello R.J. Apoptosis: a different type of cell death. Fedn Am. Soc. exp. Biol. J. 6:1992;2450-2455.
10. Glenner G.G., Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. biophys. Res. Commun. 120:1984;885-890.
11. Gong J., Traganos F., Darzynkiewicz Z. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Analyt. Biochem. 218:1994;314-319.
12. Hansen M.B., Nielsen S.E., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. immun. Meth. 119:1989;203-210.
13. Koh J.Y., Yang L.L., Cotman C.W. Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533:1990;315-320.
14. 2. Archs Biochem. Biophys. 335:1996;381-387.
15. Laczko I., Holly S., Konya Z., Soos K., Varga J.L., Hollosi M., Penke B. Conformational mapping of amyloid peptides from the putative neurotoxic 25-35 region. Biochem. biophys. Res. Commun. 205:1994;25-35.
16. Loo D.T., Copani A., Pike C.J., Whittemore E.R., Walencewicz A.J., Cotman C.W. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. natn. Acad. Sci. U.S.A. 90:1993;7951-7955.
17. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg L., Rydel R.E. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:1992;376-389.
18. Moore K.J., Matlashewski G. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J. Immun. 152:1994;2930-2937.
19. Mosmann T. Rapid colorimetric assay for cellular growth and cytotoxicity assays. J. immun. Meth. 65:1993;55-58.
20. Ormerod M.G., Sun X.M., Brown D., Snowden R.T., Cohen G.M. Quantification of apoptosis and necrosis by flow cytometry. Acta oncol. 32:1993;417-424.
21. Pakaski M., Farkas Z., Soos K., Penke B., Kasa P. Role of Leu 34-Met 35 in neurotoxicity caused by beta-amyloid 1-42 peptide in vitro. Neurobiology. 4:1996;273-274.
22. Penke B., Soos K., Varga J., Szabo E. Z., Marki-Zay J., Pakaski M. and Kasa P. (1993) Amyloid peptides, peptide hormones and the Alzheimer disease. Abstract of 13th American Peptide Symposium, Edmonton, p. 415.
23. Perry G., Cras P., Siedlak S.L., Tabaton M., Kawai M. β protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease. Am. J. Path. 140:1992;283-290.
24. Pike C.J., Walencewicz A.J., Glabe C.G., Cotman C.W. Aggregation-related toxicity of synthetic β-amyloid protein in hippocampal cultures. Eur. J. Pharmac. 207:1991;367-368.
25. Pike C.J., Walencewicz A.J., Glabe C.G., Cotman C.W. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563:1991;311-314.
26. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13:1993;1676-1687.
27. Pike C.J., Walencewicz A.J., Kosmoski J., Cribbs D.H., Glabe C.G., Cotman C.W. Structure-activity analyses of β-amyloid peptides: contributions of the β25-35 region to aggregation and neurotoxicity. J. Neurochem. 64:1995;253-265.
28. Pittman R.N., Wang S., DiBenedetto A.J., Mills J.C. A system for characterizing cellular and molecular events in programmed neuronal cell death. J. Neurosci. 13:1993;3669-3680.
29. Rosette C.D., DeTeresa P.S., Pallavicini M.G. Simultaneous flow cytometric detection of cellular c-myc protein, incorporated bromodeoxyuridine, and DNA. Cytometry. 11:1990;547-551.
30. Schwartzman R.A., Cidlowski J.A. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr. Rev. 14:1993;133-151.
31. Selkoe D.J., Abraham C.R., Podisny M.B., Duffy L.K. Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease. J. Neurochem. 46:1986;1820-1834.
32. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron. 6:1991;487-498.
33. Shigeno T., Yamasaki Y., Kato G., Kusaka K., Mima T., Takakura K., Graham D., Furukawa S. Reduction of delayed neuronal death by inhibition of protein synthesis. Neurosci. Lett. 120:1990;117-119.
34. Smith C. A., Grimes E. A., McCarthy N. J. and Williams G. T. (1994) Multiple gene regulation of apoptosis: significance in immunology and oncology in apoptosis. In The Molecular Basis of Apoptosis in Disease (eds Tomei L. D. and Cope F. O.), Vol. 8, pp. 43-87. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
35. Wyllie A.H., Kerr J.F.R., Currie A.R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:1980;251-306.
36. Yankner B.A., Caceres A., Duffy L.K. Nerve growth factor potentiates the neurotoxicity of β-amyloid. Proc. natn. Acad. Sci. U.S.A. 87:1990;9020-9023.
37. Yankner B.A., Duffy L.K., Kischner D.A. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science. 250:1990;279-282.